Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
Source check: Source checked. Not independent scientific confirmation.
Finding: Kaplan-Meier/ROC analyses and the independent GSE39055 cohort assessed survival stratification; the source reports an independent prognostic association. This remains retrospective bioinformatic evidence and does not establish treatment response or prospective clinical value.
Technology: Repeated lasso-Cox selection and multivariable Cox modeling formed a 13-lncRNA autophagy-related prognostic score for osteosarcoma.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Repeated lasso-Cox selection and multivariable Cox modeling formed a 13-lncRNA autophagy-related prognostic score for osteosarcoma.
- Test and result
- Kaplan-Meier/ROC analyses and the independent GSE39055 cohort assessed survival stratification; the source reports an independent prognostic association.
- Limitation / still unknown
- This remains retrospective bioinformatic evidence and does not establish treatment response or prospective clinical value.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.615084/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.